← back to search

Jinshi Zuo

Hebei Medical University · CN
Area of research
Pulmonary and Respiratory Medicine · Health, Toxicology and Mutagenesis
Research interest
Research interests include Ferroptosis and cancer prognosis, Air Quality and Health Impacts, Cancer, Lipids, and Metabolism, and Liver Disease Diagnosis and Treatment.
h-index
6
citations
108
works
12
NIH funding
primary concept
email

Recent publications

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
Frontiers in Pharmacology 2025cited by 7position: middledoi
Effect of Probiotics Containing Lactobacillus plantarum on Blood Lipids: Systematic Review, Meta-Analysis, and Network Pharmacological Analysis
Foods 2025cited by 3position: firstdoi
Exposure to volatile organic compounds and growth indicators in adolescents: Unveiling the association and potential intervention strategies
Journal of Hazardous Materials 2024cited by 17position: middledoi
Flaxseed Oil Alleviates PFOS-Induced Liver Injury by Regulating Hepatic Cholesterol Metabolism
Journal of Agricultural and Food Chemistry 2024cited by 12position: middledoi
Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats
Journal of Functional Foods 2024cited by 7position: middledoi
Effects of Sesamin in Animal Models of Obesity-Associated Diseases: A Systematic Review and Meta-Analysis
Nutrition Reviews 2024cited by 6position: firstdoi
Flaxseed oil attenuates PFOS-induced testicular damage by regulating RNA alternative splicing
Food & Function 2024cited by 4position: middledoi
Association between composite dietary antioxidant index and cardiovascular health: Results from two observational studies
Journal of Functional Foods 2024cited by 3position: middledoi
Exploring the mechanism of sesamin for the treatment of PM2.5-induced cardiomyocyte damage based on transcriptomics, network pharmacology and experimental verification
Frontiers in Pharmacology 2024cited by 2position: middledoi
Integrative Analysis of Pharmacology and Transcriptomics Predicts Resveratrol Will Ameliorate Microplastics-Induced Lung Damage by Targeting Ccl2 and Esr1
Toxics 2024cited by 2position: middledoi
Astaxanthin alleviates PM2.5-induced cardiomyocyte injury via inhibiting ferroptosis
Cellular & Molecular Biology Letters 2023cited by 32position: middledoi
Astaxanthin alleviates fine particulate matter (PM<sub>2.5</sub>)-induced lung injury in rats by suppressing ferroptosis and apoptosis
Food & Function 2023cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Huanting Pei · Hebei Medical University10 papers (2023–2025)Jingyi Ren · Hebei Medical University8 papers (2023–2025)Bowen Yin · Hebei Medical University6 papers (2023–2025)Ziyi Wang · Kunming University of Science and Technology5 papers (2023–2025)Wen Rui · Chinese Academy of Sciences5 papers (2023–2025)Yuxia Ma · Hebei Medical University5 papers (2024–2024)Zhenao Zhang · Hebei Medical University5 papers (2024–2025)Yadong Zhang · Hebei Medical University4 papers (2024–2025)Yuxia Ma · Southwest Petroleum University4 papers (2023–2025)Xuanyi Liu · Hebei Medical University4 papers (2023–2025)Yadong Zhang · Hebei Medical University4 papers (2023–2024)Siqi Zhu · Chinese Academy of Tropical Agricultural Sciences4 papers (2023–2025)Dan Huang · Hebei Medical University3 papers (2024–2025)Jiarui Liu · Nanjing Agricultural University3 papers (2024–2024)Miaomiao Lu · Hebei Medical University3 papers (2024–2025)Shuman Zhen · Hebei Medical University2 papers (2024–2024)Weican Zhang · Chinese Academy of Sciences2 papers (2023–2024)Yadong Zhang · Boston Children's Hospital2 papers (2024–2024)Xiaoya Sun · Hebei Medical University2 papers (2024–2024)Xiaoya Sun · Hebei Medical University2 papers (2023–2024)